Anugerah 88 Logo
$9.10+0.40|(+4.60%)
52W H: 10.1452W L: 4.5Beta: -5.65

About Alpha Cognition Inc

Frequently Asked Questions

What is the 52-week range for ACOG?

The 52-week high is $10.14 and the 52-week low is $4.5.

What is the P/E ratio for ACOG?

The P/E ratio data is currently unavailable.

What is the dividend yield for ACOG?

This company does not currently pay a dividend or the data is unavailable.

What is the Return on Equity (ROE)?

The trailing twelve months (TTM) Return on Equity is -45.33%.

What is the Net Profit Margin?

The Net Profit Margin (TTM) is -153.61%.

What is the Price to Book (P/B) Ratio?

The annual Price to Book ratio stands at 2.26.

Analyst Recommendation Trends

Wall Street analyst consensus for ACOG over the last few months:

2026-09-01
Buy: 8
S.Buy: 2
Hold: 1
Sell: 0
2026-08-01
Buy: 7
S.Buy: 2
Hold: 1
Sell: 0
2026-07-01
Buy: 6
S.Buy: 2
Hold: 1
Sell: 0
2026-06-01
Buy: 6
S.Buy: 2
Hold: 1
Sell: 0

Latest ACOG News

Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

VANCOUVER, British Columbia & GRAPEVINE, Texas, October 02, 2026--Alpha Cognition Inc. (NASDAQ: ACOG) ("Alpha Cognition", "ACI", or the "Company"), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, today announced that on October 1, 2026, the Compensation Committee of the Company’s Board of Directors (the "Compensation Committee") granted inducement awards consisting of nonstatutory stock options to purchase 6,000 shares of common stock to a

Yahoo10/2/2026

Alpha Cognition Announces CONVERGE Real-World Evidence on ZUNVEYL®(Benzgalantamine) Use in Long-Term Care

VANCOUVER, British Columbia & GRAPEVINE, Texas, October 01, 2026--Alpha Cognition Inc. (NASDAQ: ACOG) ("Alpha Cognition," "ACI," or the "Company") today announced initial results from CONVERGE, an ongoing retrospective real-world evidence evaluation using longitudinal long-term care medication-administration data. As part of the ongoing CONVERGE evidence-generation program, this analysis focused on 180-day titration and concomitant medication patterns among residents receiving ZUNVEYL (benzgalan

Yahoo10/1/2026

Alpha Cognition Announces Data From Its 180-Day Analysis Of Its CONVERGE PRogram For Patients Receiving ZUNVEYL, Donepezil, Galantamine Or Rivastigmine

Alpha Cognition Inc. (NASDAQ: ACOG) ("Alpha Cognition," "ACI," or the "Company") today announced initial results from CONVERGE, an ongoing retrospective real-world evidence evaluation using

Benzinga10/1/2026

Related Stocks (Peers)

Companies operating in similar sectors to ACOG:

ZYMEEDT.TOMSCL.TOACOGENGNCOV.VONCO.NEPMNXENE

Recent Insider Transactions

DateNameShares ChangedPriceValue
2026-09-25Opaleye Management Inc.+13,426$8.47$113,718
2026-09-24Opaleye Management Inc.+18,337$8.5664$157,082
2026-09-16Opaleye Management Inc.+27,141$8.4$227,984
2026-09-16Opaleye Management Inc.+53,029$8.5728$454,607
2026-09-15Opaleye Management Inc.+3,375$8.5424$28,831
2026-09-14Opaleye Management Inc.+40,373$8.696$351,084
2026-08-21Wills Robert James+10,000$9.62$96,200
2026-08-03Opaleye Management Inc.+50,000$8$400,000
2026-07-31Opaleye Management Inc.+2,900$7.9226$22,976
2026-07-24Opaleye Management Inc.+130$7.9$1,027
2026-07-23Opaleye Management Inc.+49,849$7.7953$388,588
2026-07-22Opaleye Management Inc.+10,000$7.8337$78,337
2026-07-22Opaleye Management Inc.+140,237$7.8337$1,098,575
2026-06-15Opaleye Management Inc.+4,550$5.9896$27,253
2026-06-12Opaleye Management Inc.+273$5.9321$1,619
2026-06-11Opaleye Management Inc.+2,862$5.9053$16,901
2026-06-10Opaleye Management Inc.+5,872$5.9873$35,157
2026-06-09Opaleye Management Inc.+24,856$5.9758$148,534
2026-06-05Opaleye Management Inc.+10,054$5.8281$58,596
2026-05-29Opaleye Management Inc.+70,577$5.8999$416,397
2026-05-28Opaleye Management Inc.+2,000$5.832$11,664
2026-05-27Opaleye Management Inc.+1,161$5.73$6,653
2026-05-21Opaleye Management Inc.+15,945$5.7$90,887
2026-05-20Opaleye Management Inc.+8,431$5.89$49,659
2026-05-19D'Angelo Lauren+3,500$5.76$20,160
2026-05-18Opaleye Management Inc.+17,395$5.6926$99,023
2026-05-15Opaleye Management Inc.+16,648$5.8257$96,986
2026-04-16Sensenig Bethany+6,991--
2026-04-16Sensenig Bethany+5,489--
2026-03-30Opaleye Management Inc.+1,850$4.9873$9,227
2026-03-27Opaleye Management Inc.+10,000$5.0792$50,792
2026-03-26Opaleye Management Inc.+7,319$5.2842$38,675
2026-03-25Opaleye Management Inc.+8,581$5.4281$46,579
2026-03-24Opaleye Management Inc.+4,182$5.59$23,377
2026-03-19Opaleye Management Inc.+2,094$5.707$11,950
2026-03-18Opaleye Management Inc.+2,481$5.749$14,263
2026-03-16Opaleye Management Inc.+1,331$5.782$7,696
2026-03-13Opaleye Management Inc.+7,358$5.747$42,286
2026-03-12Opaleye Management Inc.+5,708$5.8543$33,416
2026-03-09Opaleye Management Inc.+2,179$5.8477$12,742
2026-03-06Opaleye Management Inc.+1,900$5.7989$11,018
2026-03-05Opaleye Management Inc.+5,000$5.7976$28,988
2026-03-05Opaleye Management Inc.+42,023$5.7976$243,633
2026-03-04Opaleye Management Inc.+19,795$5.8096$115,001
2026-03-03Opaleye Management Inc.+5,000$5.7502$28,751
2026-03-03Opaleye Management Inc.+46,411$5.7502$266,873
2026-03-02Opaleye Management Inc.+20,000$5.8$116,000
2026-02-27Opaleye Management Inc.+3,638$5.9915$21,797
2026-02-26Opaleye Management Inc.+590$5.985$3,531
2026-02-24Opaleye Management Inc.+5,000$5.8004$29,002
2026-02-24Opaleye Management Inc.+53,591$5.8004$310,849
2026-02-23Opaleye Management Inc.+4,181$5.8923$24,636
2026-02-23Opaleye Management Inc.+95,819$5.8923$564,594
2026-02-20Opaleye Management Inc.+2,819$5.8411$16,466
2026-02-20Opaleye Management Inc.+10,000$5.8411$58,411
2026-01-14MERTZ PHILLIP JOSEPH+8,437--
2026-01-14MERTZ PHILLIP JOSEPH+7,241--
2026-01-14MERTZ LEONARD POWELL+8,437--
2026-01-14MERTZ LEONARD POWELL+7,241--
2026-01-14CAWKELL KENNETH ANTHONY+8,437--
2026-01-14CAWKELL KENNETH ANTHONY+7,241--
2026-01-14BAKSHI RAJEEV KUMAR+8,437--
2026-01-14BAKSHI RAJEEV KUMAR+7,241--
2026-01-14Wills Robert James+8,437--
2026-01-14Wills Robert James+7,241--
2026-01-09McFadden Michael E.+76,220--
2026-01-09McFadden Michael E.+177,576--
2026-01-09McFadden Michael E.+190,549--
2026-01-09D'Angelo Lauren+106,545--
2026-01-09D'Angelo Lauren+137,195--
2026-01-09DU HENRY HUY+15,982--
2026-01-09DU HENRY HUY+20,579--